siRNA, Anti-CDAN1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT56602WQ-2OMe)

The product SIRGT56602WQ-2OMe is a type of small interfering RNA (siRNA) that targets CDAN1 gene and regulates the expression of gene. The siRNA interferes with the expression of CDAN1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_138477.3
Alternative Names CDA1; CDAI; CDAN1A; DLT; PRO1295
Related Diseases Anemia
Purification HPLC
Target Gene
Gene ID 146059
Uniprot ID Q8IWY9
Sub Cat Target Species Modification Scale  
SIRGT57602WQ-2F CDAN1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT58602WQ-2MOE CDAN1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT59602WQ-LNA CDAN1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT56602WQ-RB CDAN1 Human Ribo-modified Inquiry
SIRGT57602WQ-BB CDAN1 Human Backbone-modified Inquiry

Related Products